The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).
 
Chizuko Kanbayashi
No Relationships to Disclose
 
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Novartis (I); Pfizer
 
Eun-Sil Shelley Hwang
No Relationships to Disclose
 
Ann H. Partridge
No Relationships to Disclose
 
Daniel William Rea
No Relationships to Disclose
 
Jelle Wesseling
No Relationships to Disclose
 
Tadahiko Shien
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Novartis
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Nihonkayaku; Novartis; Pfizer; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Eisai (Inst); Nihonkayaku (Inst)
 
Tomonori Mizutani
No Relationships to Disclose
 
Taro Shibata
No Relationships to Disclose
 
Hiroji Iwata
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Pfizer
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Pfizer (Inst)